How SGLT2 Inhibitors and GLP-1 Agonists are Transforming CKD Care

Dr. Katherine Tuttle, a leading nephrologist and researcher, discusses how groundbreaking therapies are reshaping the future of kidney care, offering hope for patients living with chronic kidney disease and redefining the role of nephrologists in value-based care.